Skip to content

Evoke and Evoke+ Ozempic Drug Trials fail to live up to Dementia promise

Over the last few years, drugs like Ozempic have gained a strong reputation for helping with more than just diabetes and weight loss. These medicines, known as GLP-1 agonists, have shown promise in improving liver, kidney, and heart... (Audio Available – 438 words – 2 minute read time)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Scientists Reverse Advanced Alzheimer’s in Mice and Restore Memory

New research is challenging that long held belief, offering a message of real hope. Scientists have shown that by fixing a fundamental problem in the brain’s energy supply, it is possible not just to slow or prevent... (Audio available – 660 words – 3 minute read time)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

New Early Prevention Drug, meet NU-9

New research from Northwestern University in the USA suggests dementia begins quietly, often many years - even decades - before any obvious memory loss shows up. The key problem seems to be tiny, harmful clumps of a protein called... (Audio available – 465 words – 2 minute read time)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Breakthrough Drug NU-9 Stops Alzheimer’s in Mice Before Signs Show Up

A fresh study from Northwestern University brings new hope in the fight against Alzheimer's disease, showing that an experimental drug called NU-9 can halt early brain changes in mice before any symptoms appear. This work uncovers a hidden trigger... (Audio Available – 801 words – 4 minute read time)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Arginine Amino Discovery

Scientists have made an exciting discovery: a natural amino acid called arginine, found in common foods, could help protect against Alzheimer's disease. This amino acid seems to stop harmful plaques from building up in the brain, which are linked... (Audio Available – 549 words – 3 minute read time)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Semaglutide Trial Ends

Novo Nordisk announced on 24 November 2025 the end of its phase 3 EVOKE and EVOKE+ trials, which investigated oral semaglutide – the active ingredient in Rybelsus, approved for type 2 diabetes – as a potential treatment... (Audio Available – 365 words – 2 minute read time)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Statins and lower cholesterol show promise in fighting Dementia, in some cases by 80%

A large genetic study suggests that popular cholesterol lowering drugs like statins could help ward off dementia by reducing harmful fat build up in blood vessels. Researchers found that people with natural gene changes that keep cholesterol levels low... (Audio Available – 575 words – 3 minute read time)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Ground-breaking Alzheimers blood test

At the European Academy of Neurology Congress in Helsinki, researchers unveiled a ground breaking blood test that could revolutionize Alzheimer’s disease management by identifying

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Donanemab and Lecanemab rejected for the NHS

Two innovative Alzheimer’s drugs, Donanemab and Lecanemab, have been rejected by the NHS due to their exorbitant cost and limited impact. These are the first treatments to slow the disease, potentially extending

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here